Details for New Drug Application (NDA): 090778
✉ Email this page to a colleague
The generic ingredient in DULOXETINE HYDROCHLORIDE is duloxetine hydrochloride. There are forty-two drug master file entries for this compound. Forty-seven suppliers are listed for this compound. Additional details are available on the duloxetine hydrochloride profile page.
Summary for 090778
| Tradename: | DULOXETINE HYDROCHLORIDE |
| Applicant: | Aurobindo Pharma Ltd |
| Ingredient: | duloxetine hydrochloride |
| Patents: | 0 |
Pharmacology for NDA: 090778
| Mechanism of Action | Norepinephrine Uptake Inhibitors Serotonin Uptake Inhibitors |
Medical Subject Heading (MeSH) Categories for 090778
Suppliers and Packaging for NDA: 090778
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| DULOXETINE HYDROCHLORIDE | duloxetine hydrochloride | CAPSULE, DELAYED REL PELLETS;ORAL | 090778 | ANDA | Major Pharmaceuticals | 0904-7043 | 0904-7043-04 | 30 BLISTER PACK in 1 CARTON (0904-7043-04) / 1 CAPSULE, DELAYED RELEASE in 1 BLISTER PACK |
| DULOXETINE HYDROCHLORIDE | duloxetine hydrochloride | CAPSULE, DELAYED REL PELLETS;ORAL | 090778 | ANDA | Major Pharmaceuticals | 0904-7043 | 0904-7043-61 | 100 BLISTER PACK in 1 CARTON (0904-7043-61) / 1 CAPSULE, DELAYED RELEASE in 1 BLISTER PACK |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE, DELAYED REL PELLETS;ORAL | Strength | EQ 20MG BASE | ||||
| Approval Date: | Dec 11, 2013 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE, DELAYED REL PELLETS;ORAL | Strength | EQ 30MG BASE | ||||
| Approval Date: | Dec 11, 2013 | TE: | AB | RLD: | No | ||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE, DELAYED REL PELLETS;ORAL | Strength | EQ 60MG BASE | ||||
| Approval Date: | Dec 11, 2013 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
